Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roger Perlmutter
Pharma
Merck preaches the value of 'focus' in $6.5B spinoff
Merck's planned spinoff will allow the company to focus on oncology and other fast-growing sectors, CEO Ken Frazier said. Analysts aren't convinced.
Arlene Weintraub
Feb 5, 2020 11:37am
Merck's $3B Keytruda haul prompts worries over future growth
Oct 29, 2019 11:40am
New Merck data adds heft to Keytruda-chemo combo win
Sep 8, 2017 10:19am
Merck's Q1 Keytruda sales double, but some aren't satisfied
May 2, 2017 12:17pm
